During ageing, and in many age-associated disorders like obesity, dyslipidaemia, hypertension, insulin resistance and neurodegenerative diseases, a low-grade, Th-1-type sustained inflammation and upregulation of IDO has been reported [87]. Here, IDO1 is linked to obesity disorder.